The highway to a candidate antibody

An integrated platform for target/antibody validation

R&D STEPS

All the expertise in one place

A unique environment for the development of immunotherapies in cancer and inflammation.

Event

Healthtech investor days

From 2020-06-24 to 2020-06-25

Come and meet us at this event

The MI-mAbs experience

The MI-mAbs experience

What our customers say

PD1/CTLA4-based Combination Models

PD1/CTLA4-based Combination Models

Using syngeneic mouse models

mAb generation

mAb generation

Making the right Ab format

In Vitro Immunopharmacology

In Vitro Immunopharmacology

ADCC & ADCC-like assays

Antibody bioproduction

Antibody bioproduction

Milligram to gram scale production

CD3ɛ humanized mice

CD3ɛ humanized mice

First model to validate bispecifics

ADC's

ADC's

Site-specific conjugation

MI-mAbs

MI-mAbs

The French demonstrator of immunotherapy antibodies